Survival after surgery in stage IA and IB non-small cell lung cancer.

ABSTRACT:

Rationale

Whether histologic subtype of non-small cell lung cancer (NSCLC) has an important effect on prognosis after surgery is unknown.

Objectives

We hypothesized that we could predict mortality more effectively by integrating precise tumor size and histology rather than relying on conventional staging.

Methods

We used the SEER (Surveillance, Epidemiology, and End Results) registry. Inclusion criteria were as follows: (1) primary squamous cell or adenocarcinoma; (2) potentially curative surgery, defined as a lobectomy or bilobectomy; (3) lymph node dissection performed; and (4) pathologic stage IA or IB.

Measurements and main results

From 1988 to 2000, 7,965 patients were included. For both all-cause and lung cancer-associated mortality, tumor size demonstrat

SUBMITTER: Ost D 

PROVIDER: S-EPMC2258444 | biostudies-literature | 2008 Mar

REPOSITORIES: biostudies-literature